MEDIA_TYPE=''
	false	false
Syöpäjärjestöt
@Syopajarjestot | 3,131 followers
Lääkkeiden hintalautakunnan johtaja Lauri Pelkonen pohtii, onko käyttöönottomenetelmillä kykyä erottaa hoidolliset edistysaskeleet niistä lääkkeistä, joilla hyötyä ei ole, ja millainen tulisi olla hinnoittelun läpinäkyvyyden. #syöpälääkkeet https://t.co/XTti67rI5k
1
  · View on Twitter

Engagement Map

Quotes
Replies
Retweets
Trendsmap
Top

Retweeters

No retweeters found
Top
Please wait while we extract and analyse the requested data.

This can take a few minutes due to the large amount of data to be searched through, extracted and analysed. Please don't reload the page in the mean time as this will only result in it taking longer.
For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.